TRUTAKNA® (atacicept) has been FDA approved for IgAN, click to aprende más. FILSPARI® (sparsentan) has also been FDA approved for FSGS and more information is coming soon. Please visit our Patient Navigation tool for support.
Empowering Students with Kidney Disease covers educational, developmental, and mental health aspects for families of K-12 students with kidney disease.
Dr. Doyle’s research and advocacy focuses on living with rare and chronic health conditions across the lifespan, with a special interest in emerging adulthood and the transition from pediatric to adult-oriented care.
Visita nuestra página de Youtube
NephCure es una organización benéfica sin fines de lucro (501c3) registrada y exenta de impuestos. EIN # 38-3569922.
© Copyright 2024 NephCure, Inc. Todos los derechos reservados en todo el mundo. NephCure y el logotipo son marcas comerciales registradas a nivel federal de NephCure, Inc.
ES 
EN 
